Anti-Anisakis Antibodies in the Clinical Course of Crohn’s Disease
- 14 May 1999
- journal article
- research article
- Published by S. Karger AG in Digestion
- Vol. 60 (3) , 268-273
- https://doi.org/10.1159/000007668
Abstract
Background: Human anisakidosis is a parasitic disease whose intestinal form shares several characterictics with Crohn’s disease (CD), like the ileocolonic location predominantly and the presence of granuloma. Methods: 73 CD patients diagnosed according to Lennard-Jones’ criteria were studied. The disease activity was measured by means of Harvey-Bradshaw Index. Different clinical variables were analyzed. Antigenic extract of Anisakis simplex larvae extracted from blue whiting was prepared. Determination of IgG, IgM, IgA and total specific immunoglobulin against A. simplex were carried out in sera by enzyme-linked immunosorbent assay. Immunorecognition patterns of these sera were realized by immunoblotting analysis. Results were compared with prevalence of antibodies anti-Anisakis in 251 healthy controls. Results: 29% of CD patients showed detectable specific total Ig (G+M+A) against A. simplex (95% CI, 19–41). For IgG, IgM and IgA the percentages were 44, 18 and 53% (95% CI, 32–56, 10–26, and 41–65) respectively. In positive specific total Ig cases CD was localized mainly in ileum. In IgG-, IgM- and IgA-positive cases the location was predominantly ileocolonic. CD activity index was higher for groups with positive IgA (2.86 vs. 5.55; p < 0.05). Conclusion: Patients with CD have high prevalence of specific immunoglobulin against A. simplex. Specific IgA are associated to higher activity index of CD.Keywords
This publication has 2 references indexed in Scilit:
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995